Table 1.
Relationship between RelB expression and clinicopathological characteristics
| Characteristics | RelB expression | P value | |
|---|---|---|---|
| High | Low | ||
| N = 60 (52%) | N = 55 (48%) | ||
| Gender | 0.731 | ||
| Male | 27 (54.0) | 23 (46.0) | |
| Female | 33 (50.8) | 32 (49.2) | |
| Age | 0.596 | ||
| Mean ± SD | 60.04 ± 10.25 | 60.19 ± 10.34 | |
| Range | 34–83 | 39–87 | |
| Smoking | 0.733 | ||
| Yes | 20 (50.0) | 20 (50.0) | |
| No | 40 (53.3) | 35 (46.7) | |
| Histology | 0.899 | ||
| ADC | 43 (51.8) | 40 (48.2) | |
| SCC | 17 (53.1) | 15 (46.9) | |
| Degree of differentiation | 0.023* | ||
| Low | 23 (67.6) | 11 (32.4) | |
| Middle | 34 (47.2) | 38 (52.8) | |
| High | 3 (33.3) | 6 (66.7) | |
| Depth of tumor invasion | <0.001* | ||
| T1 | 10 (29.4) | 24 (70.6) | |
| T2 | 28 (53.9) | 24 (46.1) | |
| T3 | 13 (72.2) | 5 (27.8) | |
| T4 | 9 (81.8) | 2 (18.2) | |
| Lymph node metastasis | 0.017* | ||
| N0 | 20 (41.7) | 28 (58.3) | |
| N1 | 30 (54.5) | 25 (45.6) | |
| N2 | 10 (83.3) | 2 (16.7) | |
| Distant metastases | 0.004* | ||
| No | 47 (47.0) | 53 (53.0) | |
| Yes | 13 (86.7) | 2 (13.3) | |
| TNM stage | <0.001* | ||
| I | 9 (27.3) | 24 (72.7) | |
| II | 17 (41.5) | 24 (58.5) | |
| III | 21 (80.8) | 5 (19.2) | |
| IV | 13 (86.7) | 2 (13.3) | |
*
The difference had statistical significance. ADC, adenocarcinoma; NSCLC, non‐small cell lung cancer; SD, standard deviation; SCC, squamous cell carcinoma; TNM, tumor node metastasis.